Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 22;13(3):230.
doi: 10.3390/toxins13030230.

Adaptation of Staphylococcus aureus in a Medium Mimicking a Diabetic Foot Environment

Affiliations
Free PMC article

Adaptation of Staphylococcus aureus in a Medium Mimicking a Diabetic Foot Environment

Cassandra Pouget et al. Toxins (Basel). .
Free PMC article

Abstract

Staphylococcus aureus is the most prevalent pathogen isolated from diabetic foot infections (DFIs). The purpose of this study was to evaluate its behavior in an in vitro model mimicking the conditions encountered in DFI. Four clinical S. aureus strains were cultivated for 16 weeks in a specific environment based on the wound-like medium biofilm model. The adaptation of isolates was evaluated as follows: by Caenorhabditis elegans model (to evaluate virulence); by quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) (to evaluate expression of the main virulence genes); and by Biofilm Ring test® (to assess the biofilm formation). After 16 weeks, the four S. aureus had adapted their metabolism, with the development of small colony variants and the loss of β-hemolysin expression. The in vivo nematode model suggested a decrease of virulence, confirmed by qRT-PCRs, showing a significant decrease of expression of the main staphylococcal virulence genes tested, notably the toxin-encoding genes. An increased expression of genes involved in adhesion and biofilm was noted. Our data based on an in vitro model confirm the impact of environment on the adaptation switch of S. aureus to prolonged stress environmental conditions. These results contribute to explore and characterize the virulence of S. aureus in chronic wounds.

Keywords: EDIN; Panton–Valentin leukocidin; Staphylococcus aureus; adaptation; biofilm; diabetic foot infection; in vitro model; nematode; virulence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Effects of a pre-culture in a wound-like medium (WLM) and 10% glucose combined with sub-minimum inhibitory concentration (MIC) of vancomycin (0.5× MIC) and linezolid (0.5× MIC) on S. aureus biofilm formation after 16 weeks of culture. The kinetics of the early phase of biofilm formation were determined on (A) NSA739; (B) NSA1077; (C) NSA7475; and (D) NSA1385 by the BioFilm ring test® (BioFilm Control, France). The control corresponds to the evaluation of biofilm formation of strains in Brain Heart Infusion (BHI) medium alone. Dotted horizontal lines: >7, no biofilm; <2, fixed biofilm. Means ± standard errors of the mean of biofilm indexes (BFIs) for at least three independent replicates are presented. Statistical differences between the different culture conditions at each time were obtained using two-way analysis of variance (ANOVA), followed by Dunnett’s multiple-comparison test.
Figure 1
Figure 1
Effects of a pre-culture in a wound-like medium (WLM) and 10% glucose combined with sub-minimum inhibitory concentration (MIC) of vancomycin (0.5× MIC) and linezolid (0.5× MIC) on S. aureus biofilm formation after 16 weeks of culture. The kinetics of the early phase of biofilm formation were determined on (A) NSA739; (B) NSA1077; (C) NSA7475; and (D) NSA1385 by the BioFilm ring test® (BioFilm Control, France). The control corresponds to the evaluation of biofilm formation of strains in Brain Heart Infusion (BHI) medium alone. Dotted horizontal lines: >7, no biofilm; <2, fixed biofilm. Means ± standard errors of the mean of biofilm indexes (BFIs) for at least three independent replicates are presented. Statistical differences between the different culture conditions at each time were obtained using two-way analysis of variance (ANOVA), followed by Dunnett’s multiple-comparison test.
Figure 2
Figure 2
Relative mRNA expression levels of toxinogenic genes of S. aureus NSA1077 strain cultivated in WLM supplemented with 10% glucose, vancomycin (0.5× MIC), linezolid (0.5× MIC), 10% glucose + vancomycin (0.5× MIC), and 10% glucose + linezolid (0.5× MIC) after 24 h (H24) and 16 weeks (W16). The log-transformed averages of relative fold changes of NSA1077 in different environmental media compared with NSA1077 in Luria-Bertani (LB) medium for 24 h and 16 weeks are presented. The error bars represent the standard deviations from the three independent RNA preparations. Significant differences from the NSA1077 in LB medium for 24 h and 16 weeks using Dunnett’s test are indicated. *, p < 0.01; ***, p < 0.001.
Figure 3
Figure 3
Relative mRNA expression levels of virulence genes and a regulator gene of S. aureus NSA739 strain cultivated in WLM supplemented with 10% glucose, vancomycin (0.5× MIC), linezolid (0.5× MIC), 10% glucose + vancomycin (0.5× MIC), and 10% glucose + linezolid (0.5× MIC) after a long exposure (16 weeks). The log-transformed averages of relative fold changes of NSA739 in different environmental media compared with NSA739 in LB medium are presented. The error bars represent the standard deviations from the three independent RNA preparations. Significant differences from the NSA739 in LB medium using Dunnett’s test are indicated. ***, p < 0.001.

Similar articles

Cited by

References

    1. Armstrong D.G., Boulton A.J., Bus S.A. Diabetic foot ulcers and their recurrence. N. Engl. J. Med. 2017;376:2367–2375. doi: 10.1056/NEJMra1615439. - DOI - PubMed
    1. Lecube A., Pachón G., Petriz J., Hernández C., Simó R. Phagocytic activity is impaired in type 2 diabetes mellitus and in-creases after metabolic improvement. PLoS ONE. 2011;6:e23366. doi: 10.1371/journal.pone.0023366. - DOI - PMC - PubMed
    1. Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P., Lauria G., Malik R.A., Spallone V., Vinik A., et al. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–2293. doi: 10.2337/dc10-1303. - DOI - PMC - PubMed
    1. Chawla R., Chawla A., Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J. Endocrinol. Metab. 2016;20:546–551. doi: 10.4103/2230-8210.183480. - DOI - PMC - PubMed
    1. Bakker K., Apelqvist J., Lipsky B.A., Van Netten J.J., Schaper N.C., International Working Group on the Diabetic Foot (IWGDF) The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: Development of an evidence-based global consensus. Diabetes Metab. Res. Rev. 2016;32:2–6. doi: 10.1002/dmrr.2694. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources